SSA & Company has appointed Philippe Rose as managing director.
Rose, who brings over 25 years of experience in chemicals and management consulting, will grow and lead the firm's European private equity and industrials practice having formerly run Celerant's Europe, Middle East and Asia (EMEA) private equity practice.
In that role, he covered the full M&A cycle, from due diligence to post-merger integration, across multiple sectors as well as working on the sell side in chemicals and pharmaceuticals.
"Increasingly, our clients ask for support of their global businesses," says Paul de Janosi, senior managing director at SSA. "Philippe is a senior leader already familiar with our approach. I had the privilege of working with him over the past decade and look forward to better serving our global clients with his addition."
"We have a proven model for value creation that holistically combines advanced analytics, digital technology, and operations transformation," says Thomas Kaiser, managing director, EMEA at SSA & Company. "With the addition of Philippe and our expanded data science team in Europe, we can better serve our growing list of global clients."
"Every company today is thinking about how to embed digital, analytics, and process automation into operations to drive revenue, enhance productivity and margins, and decrease risk," says Rose. "SSA's approach brings a new dimension to private equity services and complements traditional M&A offerings. What drew me to SSA is its specialised service model of using experts to help clients enhance operating models and build agile organisations that accelerate and sustain growth in the digital era."
